Panel Discussion: Merck R&D’s Digitally-Enabled Clinical Trial Team
***Tuesday, January 12, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET***Merck’s Digitally-Enabled Clinical Trial Initiative Members or “Smart Team” will discuss their experiences introducing digital technologies into the clinical trial paradigm and within their function. *** On demand available after final airing until Jan. 12, 2021 ***
Register Free:
Event Overview: Members of Merck’s Digitally-Enabled Clinical Trials Initiative Team will discuss their experiences introducing digital technologies into the clinical trial paradigm. Internally dubbed the “Smart Team” within Merck R&D, members from this cross-functional team, including representatives from Global Digital Analytics & Technologies, Global Clinical Supply, Information Technology, and Pharmacokinetics, Pharmacodynamics, and Drug Metabolism will share the impact of adopting digital technologies within their function.
The discussion will be based on their article, “
*The American Society of Clinical Pharmacology and Therapeutics (ASCPT) has graciously made Merck’s research article available on the Clinical and Translational Science website.
Key Learning Objectives:
- Attendees will
- Learn from the panel's experience in pilot testing and clinical trial deployment in the following four key areas:
- Smart Dosing: Use of technologies that can monitor and improve patient adherence to protocol
- Patient-Centric Sampling: Collection of pharmacokinetic, pharmacodynamic, and biomarker samples in an outpatient setting
- Digital Biomarkers: Use of digital devices to collect and measure physiological and behavioral data
- Digital Platform: Use of data platforms that integrate digital data streams, visualize data in real-time, and provide a means of greater patient engagement during the trial
- Learn about the change to synergistic power of jointly implementing these approaches within a trial to enable better understanding of patient adherence, safety, efficacy, and PK/PD relationships of investigational therapies as well as reduced patient burden for clinical trial participants.
- Learn about the challenges to adoption and to the full realization of patient-centric, digitally-enabled trials
Speakers: Dr. Lisa Shipley, Vice President of Global Digital and Analytics Technologies, Merck & Co., Inc.
Dr. Marissa Dockendorf, Director of Digital Analytics in the Global Digital Analytics and Technologies, Merck & Co., Inc.
Dr. Kevin Bateman, Scientific Associate Vice President, Merck & Co., Inc.
Dr. Bryan J. Hansen, Associate Principal Scientist in the Global Digital Analytics and Technologies, Merck & Co., Inc.
Matt Moyer, Director of Clinical Supply Technology, Merck & Co., Inc.
Jyoti Shah, Associate Director of Data Science & Scientific Informatics, Merck & Co., Inc.
Moderator: John Musaus, Founder & Executive Director, Adherence Measurement Institute
Time and Date: Tuesday, January 12, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET
On demand available after final airing until Jan. 12, 2021
Register free:
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- The Impact of ICH E6(R3) on Biospecimen Management
June 25th 2025
- The Top 5 Myths About eCOAs In 2025
March 25th 2025